FMP
Regencell Bioscience Holdings Limited
RGC
NASDAQ
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
12.62 USD
-1.47 (-11.65%)
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
386.98k
59.41k
16.42M
11.56M
7.96M
-
-
-
-
-
Total Cash %
100
100
100
100
100
100
100
100
100
Receivables
-
-
-
-
152.78k
-
-
-
-
-
Receivables %
100
100
100
100
100
100
100
100
100
Inventories
-
-7.44k
-27.6k
-56.55k
-
-
-
-
-
-
Inventories %
100
100
100
100
100
100
100
100
100
Payable
-
-
-
-
-
-
-
-
-
-
Payable %
100
100
100
100
100
100
100
100
100
Cap Ex
-117.84k
-
-780.88k
-27.39k
-5.38k
-
-
-
-
-
Cap Ex %
100
100
100
100
100
-
-
-
-
